Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Bluemtec Co's Enterprise Value is ₩96,894 Mil.
Bluemtec Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ₩-5 Mil. Therefore, Bluemtec Co's EV-to-EBIT ratio for today is -20,493.60.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Bluemtec Co's Enterprise Value is ₩96,894 Mil.
Bluemtec Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₩2,219 Mil. Therefore, Bluemtec Co's EV-to-EBITDA ratio for today is 43.67.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Bluemtec Co's Enterprise Value is ₩96,894 Mil.
Bluemtec Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ₩205,083 Mil. Therefore, Bluemtec Co's EV-to-Revenue ratio for today is 0.47.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Bluemtec Co's Enterprise Value is ₩96,894 Mil.
Bluemtec Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₩-1,326 Mil. Therefore, Bluemtec Co's EV-to-FCF ratio for today is -73.10.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Bluemtec Co (XKRX:439580) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Bluemtec Co's current Enterprise Value is ₩96,894 Mil.
Bluemtec Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-5 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Bluemtec Co's current Enterprise Value is ₩96,894 Mil.
Bluemtec Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,219 Mil.
Bluemtec Co's current Enterprise Value is ₩96,894 Mil.
Bluemtec Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩205,083 Mil.
Bluemtec Co's current Enterprise Value is ₩96,894 Mil.
Bluemtec Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,323 Mil.
Bluemtec Co's current Enterprise Value is ₩96,894 Mil.
Bluemtec Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,326 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bluemtec Co Enterprise Value Related Terms
Bluemtec Co Enterprise Value Historical Data
* Premium members only.
The historical data trend for Bluemtec Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bluemtec Co Enterprise Value Competitor Comparison
For the Pharmaceutical Retailers subindustry, Bluemtec Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bluemtec Co Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bluemtec Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Bluemtec Co's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Bluemtec Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bluemtec Co (XKRX:439580) has a Enterprise Value of ₩96,894 Mil as of Sep. 04, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Bluemtec Co and its competitors.
Is Bluemtec Co's Enterprise Value too high?
Bluemtec Co's current Enterprise Value is ₩96,894 Mil. Overall, Bluemtec Co has a GF Score™ of 47/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bluemtec Co's Enterprise Value compare to competitors?
Bluemtec Co's Enterprise Value of ₩96,894 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Bluemtec Co and its competitors. Bluemtec Co's current Enterprise Value is ₩96,894 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bluemtec Co stock overvalued right now?
Based on GuruFocus' analysis, Bluemtec Co (XKRX:439580) is currently considered Significantly Undervalued. The stock's GF Value™ is ₩6,818.30, compared to a current price of ₩1,996.00 — trading 70.7% below its estimated fair value. The current Enterprise Value is ₩96,894 Mil. Bluemtec Co's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Bluemtec Co (XKRX:439580), the current Enterprise Value is ₩96,894 Mil as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bluemtec Co (XKRX:439580) Overvalued in 2026?
Based on GuruFocus' analysis, Bluemtec Co stock appears to be undervalued.
The current stock price of ₩1,996.00 is trading 70.7% below its estimated GF Value™ of ₩6,818.30.
GuruFocus considers Bluemtec Co to be Significantly Undervalued.
Key valuation signals for XKRX:439580:
Enterprise Value: ₩96,894 Mil
GF Value™: ₩6,818.30 vs. price of ₩1,996.00 (70.7% below fair value)
No single metric tells the full story. See the XKRX:439580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, it is operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.
47GF Score
Get the complete analysis for XKRX:439580
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:439580 has been successfully added to your 
